Proxima Supper Series

The Proxima Supper Series brings together an intimate group of senior healthcare leaders for an off-the-record dinner conversation you won't find anywhere else. We're thrilled to partner with Convoke on our inaugural event in San Francisco to discuss the evening's theme: Moving biopharma at agent speed; what is hype versus what is real in accelerating drug discovery + development with AI. We'll be joined by Convoke's Founder Maged Korga Ahmed (bio below). Space is limited. RSVP today to secure your seat.About Convoke Convoke is building the AI-native operating system for drug development. Planning and executing a modern drug launch is one of humanity’s most cognitively complex coordination tasks—not unlike a rocket launch. Biopharma companies must pull together information from thousands of point solutions, share it across hundreds of siloed contributors inside and outside of their organizations, all while keeping everything up to date.In aggregate, this information processing burden is a meaningful drag on industry productivity. However, advances in machine learning can empower teams to learn and iterate faster—to move at the speed of silicon, not humans. Convoke's vision is to build an autonomous system that shepherds the next generation of drugs to market. Convoke believes that as new platforms and modalities proliferate and commodify—and our ability to control human biology democratizes—what will ultimately differentiate drug programs will not be their chemical matter, but how they are developed. About Maged Korga Ahmed Maged is a co-founder of Convoke, a Kleiner Perkins and Dimension backed technology company building an autonomous workforce for the biopharma industry. Convoke's software is deployed across top-30 pharma companies and biotechs, supporting development and commercial teams. Maged previously worked in the self-driving industry, on the founding team of Applied Intuition where he led their data and AI product suite as the company grew to a $15B critical automotive software supplier.